stella
beta
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease — Stella
Recruiting
Back to Pneumonia, Pneumocystis trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
Tongji Hospital, Wuhan, Hubei
View full record on ClinicalTrials.gov